Cleared Traditional

K911417 - ICON STREP B IMMUNOENZYMETRIC ASSAY

K911417 is the FDA 510(k) clearance for ICON STREP B IMMUNOENZYMETRIC ASSAY by Hybritech, Inc.. It is a Class 1 Microbiology device (product code GTZ) cleared through the Traditional 510(k) pathway after a 114-day FDA review.

K911417 · Hybritech, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1991
Decision
114d
Days
Class 1
Risk

K911417 is an FDA 510(k) clearance for the ICON STREP B IMMUNOENZYMETRIC ASSAY. Classified as Antisera, All Groups, Streptococcus Spp. (product code GTZ), Class I - General Controls.

Submitted by Hybritech, Inc. (San Diego, US). The FDA issued a Cleared decision on July 24, 1991 after a review of 114 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Hybritech, Inc. devices

Submission Details

510(k) Number K911417 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 1991
Decision Date July 24, 1991
Days to Decision 114 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d slower than avg
Panel avg: 102d · This submission: 114d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GTZ Antisera, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTZ Antisera, All Groups, Streptococcus Spp.

All 62
Devices cleared under the same product code (GTZ) and FDA review panel - the closest regulatory comparables to K911417.
STREP A OIA
K915758 · Biosearch Medical Products, Inc. · Jan 1992
OIA STREP A
K912889 · Biosearch Medical Products, Inc. · Oct 1991
GROUP A STREP POSITIVE AND NEGATIVE CONTROLS
K912868 · Quidel Corp. · Aug 1991
REDITEST STREP A TEST KIT
K903194 · Boehringer Mannheim Corp. · Aug 1990
PATHO DX STREP D
K902038 · Diagnostic Products Corp. · May 1990
TESTPACK PLUS STREP A
K901274 · Abbott Laboratories · May 1990